22
ICCS 2011
SUNDAY, OCTOBER 16 - PM
1:00 - 3:00 PM
Grand Ballroom II
Plenary Session I – Regulatory Issues
Chair(s): Teri Oldaker
1:00
Development and Validation of
Laboratory-Fluorescent Cell-based
Developed Tests
Bruce Davis
Trillium Diagnostics, LLC, USA
1:40
Interoperability and Standards -
Toward an Integrated Pathology
Workflow
Harry Solomon
GE Healthcare, USA
2:20
An Introduction to the 510(k)
Process for IVD Clearance
Gerald Marti
Food & Drug Administration, USA
3:00 - 4:30 PM
Grand Ballroom I
Exhibits/Coffee Break
4:30 - 5:30 PM
Grand Ballroom I
Poster Session I (Non-CME)
Poster abstracts available on Pages 37-73.
P1
WT1 RNA Expression In Different Cell
Lineages In Normal And Leukemic Bone
Marrow
Daphne C. Ang, Fei Yang, Ginny Lanier,
Richard Press, Guang Fan
OHSU, Portland, OR, USA
P3
Critical Assessment of Cell Population
Identification Techniques for Flow
Cytometry Data: Results of FlowCAP-1
Ryan Brinkman
1
, Nima Agheepour
1
, Richard
Scheuermann
2
, Raphael Gottardo
3
, Tim
Mosmann
4
1
British Columbia Cancer Agency,
Vancouver, BC, Canada,
2
University of
Texas Southwestern, Dallas, TX, USA,
3
Fred
Hutchinson Cancer Research Center, Seattle,
WA, USA,
4
Univeristy of Rochester, Rochester,
NY, USA